ArticleFrontiers in immunology2021

Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.

Jose Alberto Choreño-Parra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.